Sign in

CIK 0001434647

  • Non-accelerated filer
  • Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205894398
Phone
+1 888-958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$224,948
in 1 filing, $225K under 10b5-1 plans

Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McFarlane Neil F. −$225K President and CEO sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2018-08-30 Mickle Travis C President & CEO Gift −18,139 123,217
2018-07-30 Delaware Street Capital Master Fund, L.P. 10% owner Purchase +304,283 $4.00 $1.2M 2,095,914
2018-05-31 Clifton R. LaDuane CFO, Secretary & Treasurer Purchase +525 $6.10 $3K 2,100
2018-05-22 Saluri Joseph Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-05-22 Tierney David S Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-05-22 Thompson Danny L Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-05-22 Plooster Matthew R Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-05-22 Pascoe Richard W Director Grant or award · Stock Option (right to buy) +15,000 15,000
2018-05-15 Cohen Daniel L EVP, Govt. & Public Relations Purchase +5,500 $6.45 $35K 35,500
2018-05-15 Cohen Daniel L EVP, Govt. & Public Relations Purchase +2,000 $6.45 $13K 2,000
2018-05-15 Cohen Daniel L EVP, Govt. & Public Relations Purchase +200 $6.45 $1K 1,450
2018-05-15 Cohen Daniel L EVP, Govt. & Public Relations Purchase +200 $6.45 $1K 1,450
2018-03-23 Thompson Danny L Director Exercise or conversion +3,333 $4.65 $15K 16,666
2018-03-23 Thompson Danny L Director Shares withheld for taxes −2,026 $7.65 $15K 14,640
2018-03-23 Thompson Danny L Director Exercise or conversion · Stock Option (right to buy) −3,333 0
2018-01-25 Sangiovanni Timothy J. VP, Corporate Controller Grant or award · Stock Option (right to buy) +30,000 30,000
2018-01-25 Guenther Sven EVP, Research & Development Grant or award · Stock Option (right to buy) +75,000 75,000
2018-01-25 Cohen Daniel L EVP, Govt. & Public Relations Grant or award · Stock Option (right to buy) +75,000 75,000
2018-01-25 Johnson Gordon K Chief Business Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2018-01-25 Clifton R. LaDuane CFO, Secretary & Treasurer Grant or award · Stock Option (right to buy) +75,000 75,000

Page 17 of 25 · 499 trades